VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 84 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $138 | -3.5% | 18,000 | -23.4% | 0.00% | – |
| Q4 2022 | $143 | -99.9% | 23,500 | -3.4% | 0.00% | – |
| Q3 2022 | $144,000 | +0.7% | 24,334 | 0.0% | 0.00% | – |
| Q2 2022 | $143,000 | -43.9% | 24,334 | +82.0% | 0.00% | -100.0% |
| Q1 2019 | $255,000 | +116.1% | 13,374 | +6.5% | 0.00% | 0.0% |
| Q4 2018 | $118,000 | -57.1% | 12,559 | -13.8% | 0.00% | 0.0% |
| Q3 2018 | $275,000 | -13.5% | 14,572 | -10.4% | 0.00% | -50.0% |
| Q2 2018 | $318,000 | +33.1% | 16,272 | +27.4% | 0.00% | +100.0% |
| Q1 2018 | $239,000 | +12.7% | 12,772 | -0.1% | 0.00% | 0.0% |
| Q4 2017 | $212,000 | – | 12,783 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |